- US11629177utility2023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods0 cites
- US11607446utility2023Personalized Immunotherapy Against Several Neuronal and Brain Tumors0 cites
- US11608370utility2023Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers0 cites
- US11603397utility2023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods0 cites
- US11576954utility2023Method for Treating Non-small Lung Cancer with a Population of Activated Cells0 cites
- US11576955utility2023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods0 cites
- US11559550utility2023Peptides and Combination of Peptides for Use in Immunotherapy Against Leukemias and Other Cancers0 cites
- US11559572utility2023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers0 cites
- US11560405utility2023Peptides and Combination Thereof for Use in the Immunotherapy Against Cancers0 cites
- US11554164utility2023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods0 cites
- US11547750utility2023Peptides and T Cells for Use in Immunotherapeutic Treatment Hepatocellular Carcinoma0 cites
- US11541107utility2023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers0 cites
- US11542303utility2023Peptides and Combination Thereof for Use in the Immunotherapy Against Cancers0 cites
← PreviousPage 9 of 9